<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>119(8)</volume><submitter>Alvarez-Diaz S</submitter><pubmed_abstract>The active vitamin D metabolite 1alpha,25-dihydroxyvitamin D3 [1alpha,25(OH)2D3] has wide but not fully understood antitumor activity. A previous transcriptomic analysis of 1alpha,25(OH)2D3 action on human colon cancer cells revealed cystatin D (CST5), which encodes an inhibitor of several cysteine proteases of the cathepsin family, as a candidate target gene. Here we report that 1alpha,25(OH)2D3 induced vitamin D receptor (VDR) binding to, and activation of, the CST5 promoter and increased CST5 RNA and protein levels in human colon cancer cells. In cells lacking endogenous cystatin D, ectopic cystatin D expression inhibited both proliferation in vitro and xenograft tumor growth in vivo. Furthermore, cystatin D inhibited migration and anchorage-independent growth, antagonized the Wnt/beta-</pubmed_abstract><journal>The Journal of clinical investigation</journal><pagination>2343-58</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC2719930</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Cystatin D is a candidate tumor suppressor  gene induced by vitamin D in human  colon cancer cells.</pubmed_title><pmcid>PMC2719930</pmcid><pubmed_authors>Astudillo A</pubmed_authors><pubmed_authors>Alvarez-Diaz S</pubmed_authors><pubmed_authors>Garcia JM</pubmed_authors><pubmed_authors>Valle N</pubmed_authors><pubmed_authors>Freije JM</pubmed_authors><pubmed_authors>Bonilla F</pubmed_authors><pubmed_authors>Lopez-Otin C</pubmed_authors><pubmed_authors>Quesada V</pubmed_authors><pubmed_authors>Munoz A</pubmed_authors><pubmed_authors>Pena C</pubmed_authors></additional><is_claimable>false</is_claimable><name>Cystatin D is a candidate tumor suppressor  gene induced by vitamin D in human  colon cancer cells.</name><description>The active vitamin D metabolite 1alpha,25-dihydroxyvitamin D3 [1alpha,25(OH)2D3] has wide but not fully understood antitumor activity. A previous transcriptomic analysis of 1alpha,25(OH)2D3 action on human colon cancer cells revealed cystatin D (CST5), which encodes an inhibitor of several cysteine proteases of the cathepsin family, as a candidate target gene. Here we report that 1alpha,25(OH)2D3 induced vitamin D receptor (VDR) binding to, and activation of, the CST5 promoter and increased CST5 RNA and protein levels in human colon cancer cells. In cells lacking endogenous cystatin D, ectopic cystatin D expression inhibited both proliferation in vitro and xenograft tumor growth in vivo. Furthermore, cystatin D inhibited migration and anchorage-independent growth, antagonized the Wnt/beta-</description><dates><release>2009-01-01T00:00:00Z</release><publication>2009 Aug</publication><modification>2025-04-19T05:36:19.484Z</modification><creation>2019-03-27T00:23:56Z</creation></dates><accession>S-EPMC2719930</accession><cross_references><pubmed>19662683</pubmed><doi>10.1172/jci37205</doi></cross_references></HashMap>